Rhumbline Advisers Legend Biotech Corp Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Legend Biotech Corp stock. As of the latest transaction made, Rhumbline Advisers holds 26,334 shares of LEGN stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,334
Previous 23,630
11.44%
Holding current value
$1.08 Million
Previous $1.33 Million
12.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
202Shares Held
74.3MCall Options Held
371KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$470 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$307 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$272 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$234 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$195 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.86B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...